Cargando…
Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
Corticosteroids may produce a paradoxical worsening of myasthenia gravis (MG) symptoms within the first weeks of treatment. We therefore wanted to assess the hypothesis that a prior infusion of intravenous immunoglobulin (IVIG) may have a protective effect. Our primary objectives were to show that t...
Autores principales: | Díez-Porras, Laura, Homedes, Christian, Alberti, Maria Antonia, Vélez-Santamaría, Valentina, Casasnovas, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421901/ https://www.ncbi.nlm.nih.gov/pubmed/32782330 http://dx.doi.org/10.1038/s41598-020-70539-4 |
Ejemplares similares
-
Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales
por: Diez Porras, Laura, et al.
Publicado: (2022) -
Eculizumab as a promising treatment in thymoma-associated myasthenia gravis
por: Vélez-Santamaría, Valentina, et al.
Publicado: (2020) -
Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre
por: Nedkova-Hristova, Velina, et al.
Publicado: (2020) -
Serum Metabolomic Response of Myasthenia Gravis Patients to Chronic Prednisone Treatment
por: Sengupta, Manjistha, et al.
Publicado: (2014) -
Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report
por: Yanagihashi, Masaru, et al.
Publicado: (2020)